NDC11 50419032515
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50419-0325-15 | 50419-0325 |
| 50419-325-15 | 50419-325 |
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50419-325 | 50419-325-15 | D | Discontinued by firm | 2026-08-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gadavist | GADOBUTROL | Bayer HealthCare Pharmaceuticals Inc. | 3c5101a0-0c7e-4078-8dc3-a57beb9a0e92 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 50419-325 |
| Gadavist | GADOBUTROL | Bayer HealthCare Pharmaceuticals Inc. | b7afe34d-b70f-41a5-b89c-561bdf29f046 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 50419-325 |
| Gadavist | GADOBUTROL | Bayer HealthCare Pharmaceuticals Inc. | bd28560f-de4d-4140-874e-31df823f4dbb | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 50419-325-15 50419-325 50419032515 |